Using haloperidol as a scaffold, new agents were designed to investigate the structural contributions of various groups to binding at CNS receptors associated with atypical antipsychotic pharmacology. It is clear that each pharmacophoric group, the butyrophenone, the piperidine and the 4-chlorophenyl moieties contributes to changes in binding to the receptors of interest. This strategy has resulted in the identification of several new agents, compounds 16, 18, 19, 23, 24 and 25, with binding profiles which satisfy our stated criteria for agents to act as potential atypical antipsychotics. This research demonstrates that haloperidol can serve as a useful lead in the identification and design of new agents that target multiple receptors associated with antipsychotic pharmacology.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267002 | PMC |
| http://dx.doi.org/10.1016/j.bmc.2011.12.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exhaustive design and screening of novel antipsychotic compounds with improved pharmacodynamics and blood-brain barrier permeation properties.
J Biomol Struct Dyn
December 2023
Laboratory of Chemoinformatics, Infochemistry Scientific Center, ITMO University, Saint-Petersburg, Russia.
Antipsychotic drugs or neuroleptics are widely used in the treatment of psychosis as a manifestation of schizophrenia and bipolar disorder. However, their effectiveness largely depends on the blood-brain barrier (BBB) permeation (pharmacokinetics) and drug-receptor pharmacodynamics. Therefore, in this study, we developed and implemented the pipeline to design novel compounds (n = 260) as leads using the standard drug scaffolds with improved PK/PD properties from the standard scaffolds.
View Article and Find Full Text PDFActivity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana.
Parasitol Int
December 2022
Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and University Hospital, Palacky University Olomouc, Czech Republic. Electronic address:
A series of 1-aryl-4-(phthalimidoalkyl) piperazines and 1-aryl-4-(naphthalimidoalkyl) piperazines were retrieved from a proprietary library based on their high structural similarity to haloperidol, an antipsychotic with antiparasitic activity, and assessed as potential antileishmanial scaffolds. Selected compounds were tested for antileishmanial activity against promastigotes of Leishmania major and Leishmania mexicana in dose-response assays. Two of the 1-aryl-4-(naphthalimidoalkyl) piperazines (compounds 10 and 11) were active against promastigotes of both Leishmania species without being toxic to human fibroblasts.
View Article and Find Full Text PDFDiscovery of Novel Dual Adenosine A and A Receptor Antagonists with 1-Pyrazolo[3,4]pyrimidin-6-amine Core Scaffold as Anti-Parkinson's Disease Agents.
Pharmaceuticals (Basel)
July 2022
Laboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, Seoul 08826, Korea.
New compounds with 1-pyrazolo [3,4]pyrimidin-6-amine core scaffolds were synthesized and characterized in vitro to determine their affinity for human A and A receptors. Among the tested compounds, a few compounds displayed nanomolar binding affinities for both receptors. One particular compound, showed high binding activities (A K = 13.
View Article and Find Full Text PDFSynthesis of Aminoethyl-Substituted Piperidine Derivatives as σ Receptor Ligands with Antiproliferative Properties.
ChemMedChem
April 2022
Institut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Corrensstraße 48, 48149, Münster, Germany.
A series of novel σ receptor ligands with a 4-(2-aminoethyl)piperidine scaffold was prepared and biologically evaluated. The underlying concept of our project was the improvement of the lipophilic ligand efficiency of previously synthesized potent σ ligands. The key steps of the synthesis comprise the conjugate addition of phenylboronic acid at dihydropyridin-4(1H)-ones 7, homologation of the ketones 8 and introduction of diverse amino moieties and piperidine N-substituents.
View Article and Find Full Text PDFStructure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from to overcome kanamycin resistance.
RSC Med Chem
November 2021
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky 789 South Limestone Street Lexington KY 40536 USA
Tuberculosis (TB), caused by (), is a deadly bacterial disease. Drug-resistant strains of make eradication of TB a daunting task. Overexpression of the enhanced intracellular survival (Eis) protein by confers resistance to the second-line antibiotic kanamycin (KAN).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!